0.861
                                            前日終値:
              $0.7851
            開ける:
              $0.78
            24時間の取引高:
                2.36M
            Relative Volume:
              0.31
            時価総額:
                $7.78M
            収益:
              -
            当期純損益:
              $-19.88M
            株価収益率:
              -0.9462
            EPS:
                -0.91
            ネットキャッシュフロー:
                $-19.93M
            1週間 パフォーマンス:
              +44.66%
            1か月 パフォーマンス:
              +45.00%
            6か月 パフォーマンス:
                -62.89%
            1年 パフォーマンス:
              -72.32%
            Purple Biotech Ltd Adr Stock (PPBT) Company Profile
PPBT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                PPBT
                            
                             
                        Purple Biotech Ltd Adr 
                           | 
                    0.861 | 7.09M | 0 | -19.88M | -19.93M | -0.91 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Purple Biotech Ltd Adr (PPBT) 最新ニュース
An analyst sees good growth prospects for Purple Biotech Ltd ADR (PPBT) - setenews.com
Purple Biotech stock soars after manufacturing milestone for tri-specific antibody - Investing.com
Dow Surges 250 Points; Verizon Posts Mixed Q3 Results - Benzinga
Purple Biotech Announces Receipt of Nasdaq Minimum Bid Price Notification - GlobeNewswire Inc.
Is Banco Santander S.A. Sponsored ADR stock a top dividend aristocrat candidateEarnings Recap Report & AI Forecast Swing Trade Picks - newser.com
Purple Biotech Enters New ATM Agreement with H.C. Wainwright - The Globe and Mail
Purple Biotech Ltd. enters $2.3M ATM - Investing.com
Purple Biotech (NASDAQ:PPBT) Trading Down 12.3% – Here’s Why - Defense World
Purple Biotech (PPBT) Stock Price, News & Analysis - MarketBeat
Clinical-Stage Cancer Drug Developer Purple Biotech to Present at Major Healthcare Conference - Stock Titan
Purple Biotech (NASDAQ:PPBT) Trading Down 4.9% Following Weak Earnings - Defense World
PPBT’s Stock Market Expedition: Traversing Gains and Losses in 2025 - investchronicle.com
Purple Biotech Highlights Clinical Milestones and Pipeline Progress in H1 2025 - TipRanks
Purple Biotech (NASDAQ:PPBT) Shares Down 2% – Here’s Why - Defense World
Kingswood Wealth Advisors LLC Has $44,000 Holdings in Purple Biotech Ltd. Sponsored ADR (NASDAQ:PPBT) - Defense World
H.C. Wainwright lifts Purple Biotech stock target to $34 By Investing.com - Investing.com South Africa
H.C. Wainwright lifts Purple Biotech stock target to $34 - Investing.com
Purple Biotech: Advancing Next-Generation Cancer Therapies - roscoeviewjournal.com
Purple Biotech appoints Shai Lankry as new CFO By Investing.com - Investing.com South Africa
Purple Biotech appoints Shai Lankry as new CFO - Investing.com
Best upcoming stock splits and reverse splits 2024 - Investorsobserver
PPBT Stock Surges 150% on Superior Efficacy of PDAC Combo Therapy - Nasdaq
Do You Know What To Trade This Month? - StocksToTrade
PPBT stock touches 52-week low at $3.52 amid market challenges - Investing.com
PPBT stock touches 52-week low at $5.89 amid market challenges - Investing.com
What Makes Purple Biotech (PPBT) a New Buy Stock - Yahoo Finance
Purple Biotech stock target cut on trial cohort issue - Investing.com
95 Promising Stocks You Can Currently Buy for Less Than $5 Per Share - GOBankingRates
Purple Biotech (PPBT) Stock Forecast and Price Target 2025 - MarketBeat
Here's Why Purple Biotech Ltd. Sponsored ADR (PPBT) Could be Great Choice for a Bottom Fisher - Yahoo Finance
symbol__ Stock Quote Price and Forecast - CNN
Purple Biotech LtdADR (PPBT) News, Articles, Events & Latest Updates - Stocktwits
What is the current Price Target and Forecast for Purple Biotech (PPBT) - Zacks Investment Research
Le 1001 azioni che si sono schiantate sul mercato azionario USA - Scenari Economici
Purple Biotech Stock: Should I invest? - Value The Markets
PPBT Stock Price and Chart — TASE:PPBT - TradingView
Purple Biotech (PPBT) Competitors and Alternatives 2025 - MarketBeat
Purple Biotech Ltd (PPBT) Stock Price, News, Quote & History - Yahoo! Finance Canada
PPBT Stock Price and Chart — NASDAQ:PPBT - TradingView
Salarius Pharmaceuticals (SLRX) Short Interest Ratio and Volume 2025 - MarketBeat
Pre-Market Stock Quote Data - Nasdaq
Can-Fite BioPharma Ltd. (CANF) Stock Price, News, Quote & History - Yahoo
Purple Biotech Ltd Adr (PPBT) 財務データ
収益
当期純利益
現金流量
EPS
                大文字化:
                 
                  | 
                ボリューム (24 時間):